A new study suggests treatment-resistant depression may be rooted in the immune system. Trauma, stress biology, and ...

Acquires next generation tissue-targeted C3d-Factor H fusion protein complement inhibitor from Q32 Bio Phase 2 basket trial ...

Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, ...

HIIT safely improves aerobic capacity and muscle endurance in newly diagnosed inflammatory muscle disease patients.

Q32 Bio shares rise after selling ADX-097 to Akebia in a deal worth up to $592 million, boosting cash runway into late 2027.

About one third of lung transplant recipients have a genetic variant that makes them more likely to develop chronic lung ...

Elevated PD-1+CD4+ T cells represent an independent risk factor for lupus nephritis (LN) and may serve as a biologically meaningful diagnostic and therapeutic target.

New research suggests that a severe and specific form of depression involves a systemic disruption linking the immune system ...

This thesis explores how newborns can be better protected against bacterial infections by studying the interplay between (monoclonal) antibodies and the immune system of the newborn. We focus on three ...

About one third of lung transplant recipients have a genetic variant that makes them more likely to develop chronic lung ...

New research suggests splitting sleep into night and daytime naps can boost memory and reduce sleep pressure, offering ...